Comparison of four contrast medium delivery protocols in low-iodine and low-radiation dose CT angiography of the aorta.

AIM: To evaluate contrast medium delivery protocols for the optimal enhancement profile of the aorta with both a reduced dose of radiation and contrast medium, called double-low computed tomography (CT) angiography (DLCTA). MATERIALS AND METHODS: DLCTA was performed with 70 kVp and 200 mg iodine/kg in 205 patients following four protocols, namely slow rate (n=52), short duration (n=52), low concentration (n=50), and combined method (n=51), in comparison with a conventional group (120 kVp, 400 mg iodine/kg, n=51). The quantitative measurement of aortic attenuation, homogeneity, and subjective scores were evaluated. RESULTS: Overall, in the four DLCTA groups, the radiation dose was reduced by 62%, and the iodine dose was reduced by 50%. Among the four DLCTA groups, the signal to noise ratio (SNR) and contrast to noise ratio (CNR) of the thoracic aorta were similar, but a significant difference was noted in the abdominal aorta. The short-duration group had the highest peak enhancement, least homogeneity, and worst subjective scores. Good contrast enhancement and good homogeneity were significantly more frequent in the slow-rate (86.6% and 90.4%, respectively) and low-concentration groups (78% and 96.0%, respectively). Subjective scores exhibited a trend of higher scores in the low-concentration group and lower scores in the slow-rate group (p=0.071). CONCLUSION: DLCTA with 70 kVp and 200 mg iodine/kg is feasible for whole-aortic CT angiography. The low-concentration protocol is recommended owing to its most consistent optimal aortic enhancement profile. Alternatively, the slow-rate protocol can be considered for patients with limited venous access.

[The analysis of health effects of exposure to occupational hazards on works in gypsum mining enterprise].

Objective: To investigate the health of gypsum miners in Hubei province and analyze the health effects of occupational disease hazards exposure on gypsum miners. Methods: In April 2017, occupational disease hazard factors were tested on the site of a gypsum mine, and 500 workers were selected by random sampling to conduct questionnaires, relevant data such as occupational health examination was collected, and descriptive statistical analysis was performed. Results: The main occupational hazards of gypsum miners were gypsum dust and noise. The time-weighted average concentration of 8 h in the workplace was 4.32 to 9.34 mg/m(3), and the post pass rate was 69.2% (9/13) ; Respiratory dust 0.13-5.15 mg/m(3), post pass rate 75.0% (3/4). Gypsum miners had finger dysfunction and muscle numbness, joint pain (29.2%, 88/301) and chest pain and breathing difficulties (17.6%, 53/301). Followed by tinnitus, auricle pus, running water (4.7%, 14/301), abnormal muscle tension (2.7%, 8/301). The exposure of occupational disease hazards was associated with respiratory, auditory and neurological symptoms of gypsum miners. Conclusion: The long-term exposure of gypsum workers to gypsum dust, noise and other harmful factors may result in obvious symptoms of respiratory system and other health damage.

Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme.

INTRODUCTION: Inflammation is a key aspect of glioblastoma multiforme (GBM) although it remains unclear how it contributes to GBM pathogenesis. Inflammasomes are intracellular multi-protein complexes that are involved in innate immunity and are activated by cellular stress, principally in macrophages. This study examined the expression of inflammasome-associated genes in GBM, particularly absent in melanoma 2 (AIM2). METHODS: Tissue samples from surgically-resected GBM tumors (n = 10) were compared to resected brain specimens from patients with epilepsy (age- and sex-matched Other Disease Controls (ODC, n=5)) by qRT-PCR, western blotting and immunofluorescence. Gene expression studies in human astrocytoma U251 cells were performed and the effects of deleting the absent in melanoma 2 (AIM2) gene using the CRISPR-Cas9 system were analyzed. RESULTS: GBM tissues showed significantly elevated expression of multiple immune (CD3E, CD163, CD68, MX1, ARG1) and inflammasome (AIM2, NLRP1, IL18, CASP1, and IL-33) genes compared to ODC tissues, without induction of IL1B, IFNG or TNFA. An insert-containing AIM2 variant transcript was highly expressed in GBM tissues and in U251 cells. AIM2 immunoreactivity was concentrated in the tumor core in the absence of PCNA immunodetection and showed a predominant 52 kDa immunoreactive band on western blot. Deletion of AIM2 resulted in significantly enhanced proliferation of U251 cells, which also displayed increased resistance to temozolomide treatment. CONCLUSIONS: GBM tumors express a distinct profile of inflammasome-associated genes in a tumor-specific manner. AIM2 expression in tumor cells suppressed cell proliferation while also conferring increased susceptibility to contemporary GBM therapy.

Performance of a patient-dedicated, on-demand blood gas monitor in medical ICU patients.

We examined the performance characteristics of a new bedside blood gas monitor. This monitor's fluorescent pH, PCO2, and PO2 sensors are embedded in a cassette, which is calibrated in vitro and then inserted into the patient's radial artery tubing set. In 50 medical ICU patients, 683 paired monitor and conventional blood gas analyzer values were obtained. Performance was assessed via calculations of bias (mean monitor and analyzer difference) and its standard deviation (SD), plots of monitor and analyzer differences against the means (of monitor and analyzer), and linear regression analysis of the sequential changes in monitor values versus the corresponding sequential changes in analyzer values. The ex vivo calibration, assessed using the initial paired blood samples, showed a bias +/- SD of 0.02 +/- 0.02 for pH, -0.1 +/- 1.9 mm Hg for PCO2, and 4.3 +/- 6.0 mm Hg for PO2. For all paired samples (n = 683), the biases +/- SD were 0.004 +/- 0.023 for pH, 0.6 +/- 2.4 mm Hg for PCO2, and 2.7 +2- 6.4 mm HG for PO2. The PO2 bias increased as PO2 increased. The standard deviations (imprecision) of both PCO2 and PO2 also increased as the magnitudes of these variables increased. Sequential changes in monitor values versus the corresponding sequential changes in analyzer values revealed regression lines close to the line of identity. Serum sodium had no effect on pH bias. Daily drift of the sensors was inconsequential, with values of -0.01/d for pH, 1.7 mm Hg/d for PCO2, and 1.1 mm Hg/d for PO2. We conclude that the performance of this monitor is comparable to that of conventional blood gas analyzers.

Variability of arterial blood gas values over time in stable medical ICU patients.

The spontaneous variability of arterial blood gas and pH values (ABGs) was examined in a group of 28 typical stable medical ICU patients under a variety of ventilatory conditions. In each patient, 13 ABG specimens were measured at 5-min intervals during a 1-h study period using a new bedside, extravascular fluorescent blood gas monitor. For all patients, the mean coefficient of variation (C) was 6.1 percent for PO2 and 4.7 percent for PCO2. The average SD for pH was 0.012. We conclude that the spontaneous variability for ABG values over a 1-h period is substantial and that this variability should be taken into account when making clinical decisions based on ABG values.

Development of a patient-dedicated, on-demand, blood gas monitor.

A new monitor (CDI 2000) that brings blood gas measurements to the patient's bedside has been developed. To measure blood gases, blood is drawn into the patient's arterial pressure-monitoring line past in-line fluorescent-based sensors. After measurement, the blood is returned to the patient, avoiding blood loss and delays in sample turnaround and reducing the risk of infection to both patient and operator. We assessed this system's performance in vitro with tonometered bovine blood. Bias (mean difference between monitor and tonometered gas or measured pH values) +/- the standard deviation (SD) were 0.01 +/- 0.02 at pH = 7.39; 0.0 +/- 0.7 mm Hg at Pco2 = 39 mm Hg; and 2.4 +/- 3.2 mm Hg at a Po2 = 100 mm Hg (n = 54). Changes in hematocrit, blood temperature, or serum sodium concentration did not have clinically significant effects on system performance. Studies in normal volunteers, in whom large changes in blood gases were induced, showed a bias (mean difference between monitor and IL 1306 values) +/- SD of 0.00 +/- 0.02 for pH, -0.4 +/- 2.0 mm Hg for Pco2, and -3.6 +/- 7.7 mm Hg for Po2 (n = 69). We conclude from the present study that the performance of this system is comparable to that of conventional blood gas analyzers.